Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis and Related Disorders|April 12, 2016
The effects of intrathecal rituximab on biomarkers in multiple sclerosisJoanne Topping, Ruth Dobson, Sergey Lapin, et al.
Therapeutic Advances in Neurological Disorders|August 4, 2025
Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brainTanja Sjöros, Maija Saraste, Markus Matilainen, et al.
BMC Neurology|August 7, 2013
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trialClaudio Gobbi, Dominik S Meier, François Cotton, et al.
Journal of Glaucoma|January 6, 2004
Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patientsOlga Golubnitschaja, Kristina Yeghiazaryan, Rong Liu, et al.
Journal of Neurochemistry|September 22, 2007
Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase responseSandra J Campbell, Yanyan Jiang, Andrew E M Davis, et al.
Multiple Sclerosis and Related Disorders|April 9, 2023
High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseasesAmin Ziaei, Zahra Nasr, Janace Hart, et al.
Frontiers in Neurology|July 1, 2022
A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based StudiesNicole Rübsamen, Eline A J Willemse, David Leppert, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysisJens Kuhle, David Leppert, Giancarlo Comi, et al.
Pageof 17